الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. | Eli Lilly | Terminated | Prasugrel | 3 | H7T-MC-TADO | King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh) |
| A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) | Merck Serono | Terminated | Lutropin alfa | 3b | EMR200061_506 | King Abdulaziz University Hospital (Jeddah) |
| SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety | SPIMACO | Terminated | Fastulin R / Normulin N | 3 | (version 1.4) Aug 2011 | King Fahad Medical City (Riyadh) |
| "A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " | Sanofi | Terminated | GLIMEPIRIDE-HOE490 | 3 | GLIME_R_05809 | King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh) |
| Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. | Servier | Terminated | Ivabradine | 3 | CL3-16257-083 | King Fahad Medical City (Riyadh) |
| A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus Bevacizumab Therapy | Roche | Terminated | Bevacizumab+ Capecitabine | 3 | MO22223 | King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| A Phase 3b, open-labeled, randomized, parallel-group, multi-center study to evaluate the safety of novartis MenACWY Conjugate Vaccine when administered with routine infant Vaccinations to healthy Infants | Novartis | Completed | Meningococcal ACWY Conjugate Vaccine | 3b | V59P23 | King Fahad Medical City (Riyadh) |
| An open-Label, multicenter, expanded access study of Everolimus in Patients with advanced Nerouendocrine tumors. | Novartis | Completed | Everolimus | 3b | CRAD001K24133 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| An Open-lable, Randomized, Multi center, Phase III Study to Compare the Saftey and Efficacy of TKI258 Versus Sorafenib in Patients with Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor Therapies" | Novartis | Completed | TKI258 / Sorafenib | 3 | CTKI258A2302 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd) | Novartis | Completed | Nilotinib | 3b | CAMN107E2401 | King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.